Related references
Note: Only part of the references are listed.Statin use and mortality in atrial fibrillation: A systematic review and meta-analysis of 100,287 patients
Daniele Pastori et al.
PHARMACOLOGICAL RESEARCH (2021)
2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation (vol 23, pg 1612, 2021)
Jan Steffel et al.
EUROPACE (2021)
Stroke and thromboembolism prevention in atrial fibrillation
Sina Jame et al.
HEART (2020)
Impact of direct-acting oral anticoagulants and warfarin on postendoscopic GI bleeding and thromboembolic events in patients undergoing elective endoscopy
Andy Tien et al.
GASTROINTESTINAL ENDOSCOPY (2020)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Craig T. January et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Safety and Effectiveness of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Anemia: A Retrospective Cohort Study
Chun-Li Wang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Effectiveness and safety of non-vitamin-K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with thrombocytopenia
Chun-Li Wang et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2019)
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study
Chun-Li Wang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Chang Gung Research Database: A multi-institutional database consisting of original medical records
Ming-Shao Tsai et al.
BIOMEDICAL JOURNAL (2017)
Risk of Upper and Lower Gastrointestinal Bleeding in Patients Taking Nonsteroidal Anti-inflammatory Drugs, Antiplatelet Agents, or Anticoagulants
Angel Lanas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
431 Upper Endoscopic Findings in Anticoagulated Patients With Atrial Fibrillation Presenting With Gastrointestinal Bleeding Predicts Outcomes
Mohammad Elbatta et al.
GASTROENTEROLOGY (2015)
Restarting Anticoagulation and Outcomes After Major Gastrointestinal Bleeding in Atrial Fibrillation
Waqas Qureshi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
Robert P. Giugliano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Apixaban in Patients with Atrial Fibrillation
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey
Ron Pisters et al.
CHEST (2010)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
Acute upper gastrointestinal bleeding in patients on long-term oral anticoagulation therapy: Endoscopic findings, clinical management and outcome
Konstantinos C. Thomopoulos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Share Paper
